1XOR | date | |
|||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
authors | |||||||||||||||
compound | source | ||||||||||||||
symmetry |
| ||||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | |||||||||||||
ligand | MG, ZAR, ZN BindingDB | enzyme |
| ||||||||||||
related structures | by homologous chain: 1XOM, 1Y2B | ||||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | Structural basis for the activity of drugs that inhibit phosphodiesterases., Card GL, England BP, Suzuki Y, Fong D, Powell B, Lee B, Luu C, Tabrizizad M, Gillette S, Ibrahim PN, Artis DR, Bollag G, Milburn MV, Kim SH, Schlessinger J, Zhang KY, Structure (Camb) 2004 Dec;12(12):2233-47. PMID:15576036 |
Data retrieval |
View 1XOR in 3D |
Visual 3D analysis of 1XOR |
Structure-derived information |
- Domain d1xora_, region A [Jmol] [rasmolscript] [script source] - Domain d1xorb_, region B [Jmol] [rasmolscript] [script source] |
Sequence-derived information |
Other resources with information on 1XOR |
Movements, Movies and Images |
OCA© by Jaime Prilusky, 1996-2014,2022,2024 Bioinformatics Unit Weizmann Institute of Science |